Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8mL dose.
Two years on, Bavarian Nordic’s $380 million vaccine M&A move appears to be paying off. | Valneva may have won the ...
Valneva SE (“Valneva”) announced that the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) ...
1d
GlobalData on MSNBavarian Nordic scoops FDA approval for chikungunya vaccine in adults and teensBavarian Nordic sets up a bout with Valneva’s Ixchiq, the former’s Vimkunya already having an edge in population reach.
Bavarian Nordic (OTCPK:BVNRY) has received FDA approval for its vaccine Vimkunya for the prevention of chikungunya. The virus-like particle, or VLP, vaccine is approved for people aged 12 and older.
1 Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ® - Valneva 2 Valneva Announces U.S. FDA Approval of World's First Chikungunya ...
approved the vaccine chikungunya vaccine (live) (brand name IXCHIQ) to protect adults against chikungunya disease, caused by the chikungunya virus (CHIKV). CHIKV is found in the subtropical regions of ...
Infected mosquitoes spread the chikungunya virus through their bites. The main transmitters are the Aedes aegypti and Aedes albopictus species. The same 2 species of mosquitoes also transmit dengue.
Colombo, February 4 (Daily Mirror) - Sri Lanka is experiencing a rise in Chikungunya cases, with the highest number of infections being reported across the country. Paediatrician at Lady Ridgeway ...
Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older
First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old. The virus-like particle (VLP) single-dose chikungunya vaccine is expected to launch in key European markets in ...
In May last year, the EMA recommended granting a marketing authorization in the EU for Ixchiq, the first vaccine in the EU to protect adults 18 years and older against chikungunya. Dr Rob Hicks is ...
SC Weaver is an inventor on a UTMB patent application describing IRES-attenuated alphavirus vaccines ... in the production of this manuscript. Chikungunya virus (CHIKV) causes an acute febrile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results